CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

pf-06372865

Small moleculeexperimental

Clinical trial activity

10 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
7
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Oct 1, 2013 (NCT01951144)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2014

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • pf-06372865
  • pf-06372865

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03351751Phase 1Nov 8, 2017Pfizer
NCT02564029Phase 2Dec 16, 2015Pfizer
NCT02475746Phase 1Jul 1, 2015Pfizer
NCT02310568Phase 2Nov 1, 2014Pfizer
NCT02262754Phase 2Oct 1, 2014Pfizer
NCT02238717Phase 1Sep 1, 2014Pfizer
NCT02217787Phase 1Sep 1, 2014Pfizer
NCT02138500Phase 1May 1, 2014Pfizer
NCT02070289Phase 1Mar 1, 2014Pfizer
NCT01951144Phase 1Oct 1, 2013Pfizer
Showing 10 of 10 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
PfizerFor profit101022013
1 organizations
Page 1 / 1